158 related articles for article (PubMed ID: 2071787)
1. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man.
Hayes JP; Ridge SM; Griffith S; Barnes PJ; Chung KF
J Allergy Clin Immunol; 1991 Jul; 88(1):83-8. PubMed ID: 2071787
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
Foster AP; Cunningham FM; Andrews MJ; Lees P
J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
[TBL] [Abstract][Full Text] [Related]
4. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
Foster AP; Lees P; Andrews MJ; Cunningham FM
Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
6. PAF-induced platelet aggregation ex vivo as a method for monitoring pharmacological activity in healthy volunteers.
Adamus WS; Heuer H; Meade CJ
Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):415-20. PubMed ID: 2747341
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation.
Adamus WS; Heuer H; Meade CJ; Frey G; Brecht HM
Eur J Clin Pharmacol; 1988; 35(3):237-40. PubMed ID: 3181277
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine.
Bastos da Silva M; Herion F; Raskinet R; David JL; Gustin P; Lekeux P
Zentralbl Veterinarmed A; 1997 Apr; 44(2):65-71. PubMed ID: 9284631
[TBL] [Abstract][Full Text] [Related]
10. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
11. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man.
Chung KF; Dent G; McCusker M; Guinot P; Page CP; Barnes PJ
Lancet; 1987 Jan; 1(8527):248-51. PubMed ID: 2880069
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P
Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
[TBL] [Abstract][Full Text] [Related]
13. The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
Bastos da Silva MB; Gustin P; Herion F; Raskinet R; David JL; Gougnard T; Plomteux G; Desmecht D; Lekeux P
Vet Res Commun; 1997 Oct; 21(7):521-31. PubMed ID: 9345719
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males.
Church MK
Br J Dermatol; 2010 Dec; 163(6):1330-2. PubMed ID: 20819087
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
Ammit AJ; O'Neill C
Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
17. Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
Watanabe M; Osada H; Shimizu S; Goto S; Nagai M; Shirai J; Sasaki K; Shimoda M; Itoh H; Ohmori K
Am J Vet Res; 2016 Sep; 77(9):969-75. PubMed ID: 27580108
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
19. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
